Dr. med. Daniel Weilenmann
chief of service
Kardiologie · Dept. I
Cruz HBR
Jul 13, 2020Post-market registry to evaluate the safety and efficacy of the Supraflex Cruz™ sirolimus-eluting coronary stent system in the treatment of all-comer patients with coronary artery disease
Clinical Studies - Jul 13, 2020 - Dec 31, 2022
Completed
Project leader: Weilenmann Daniel
Members: Schneider Irene, Fink Karin
LEADERS FREE III
Aug 1, 2017A study evaluating the safety and efficacy of the BioFreedomTM Biolimus A9TM coated Cobalt Chromium coronary stent system in patients at high risk of bleeding. The objective of this study is to evaluate if the BioFreedomTM CoCr Drug Coated stent has...
Clinical Studies - Aug 1, 2017 - Dec 31, 2021
Completed
Project leader: Weilenmann Daniel
Members: Vetsch Susanne
WIN: Worldwide registry to assess the STENTYS XPOSITION S for revascularization of coronary arteries In routine cliNical practice
Jan 27, 2017To assess the long term safety and efficacy of the XPOSITION S STENT in routine clinical practice. Inclusion of subjects with coronary artery disease, including patients with chronic stable angina, silent ischemia and acute coronary syndrome, who qua...
Clinical Studies - Jan 27, 2017 - Jan 31, 2020
Completed
Project leader: Weilenmann Daniel
Members: Schneider Irene
BIOSTEMI und BIOSTEMI Ext
Oct 12, 2016Mit dieser Studie wird die Sicherheit und Effektivität von zwei medikamentenbeschichteten Stents bei Patienten, die einen STEMI erlitten haben verglichen. Es wird geprüft, ob der Stent mit einer selbst auflösenden Beschichtung bei Patienten mit einem...
Clinical Studies - Oct 12, 2016 - Dec 30, 2023
Completed
Project leader: Weilenmann Daniel
Members: Schneider Irene
TRUNC - Multicenter prospective study of the STENTYS Xposition S for treatment of unprotected Left Main Coronary Artery Disease
May 2, 2016To assess the long-term safety and efficacy of the Xposition S stent (self-expanding sirolimus-eluting stent with a durable polymer coating) in the treatment of unprotected left main coronary artery disease. Primary clinical endpoint: Target Lesion...
Clinical Studies - May 2, 2016 - Dec 31, 2019
Completed
Project leader: Weilenmann Daniel
Members: Schneider Irene
COBRA REDUCE - Cobra PzF Stenting to Reduce the Duration of Triple Therapy in Patients Treated with Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
Jan 1, 2016Hypothesis: In patients undergoing coronary intervention who are receiving oral anticoagulation, Cobra PzF stents with 14 days of DAPT after stenting provide superior outcomes versus Xience/Promus or Resolute drug-eluting stents with 6 months of DAPT...
Clinical Studies - Jan 1, 2016 - Mar 31, 2019
Completed
Project leader: Weilenmann Daniel
Members: Schneider Irene
SENIOR
Mar 26, 2015Kurzzeitige duale Thrombozytenaggregationshemmer-Therapie mit Everolimus freisetzenden Stents Synergy® II bei Patienten über 75 Jahren, die eine perkutane Koronarrevaskularisierung erhalten. Ziele: Nachweis der Wirksamkeit und Sicherheit der Everol...
Clinical Studies - Mar 26, 2015 - Nov 30, 2018
Completed
Project leader: Weilenmann Daniel
Members: Schneider Irene
AMG 145 20120153 GLAGOV
Jan 9, 2014Double-Blind, Randomized, Multi-Center, Placebo-Controlled, Parallel Group Study to Determine the Effects of Evolocumab (AMG 145) Treatment on Atherosclerotic Disease Burden As Measured By Intravascular Ultrasound in Subjects Undergoing Coronary Cath...
Clinical Studies - Jan 9, 2014 - Jan 9, 2018
Completed
Project leader: Rickli Hans
Members: Weilenmann Daniel, Gemperle Michaela, Rigger Johannes
Absorb first registry
Jul 10, 2013A global post-market registry of patients with de novo lesions in previously untreated vessels treated with Absorb BVS per IFU (on-label use)
Clinical Studies - Jul 10, 2013 - Oct 1, 2015
Completed
Project leader: Weilenmann Daniel
Members: Vollenbroich Rene, Gemperle Michaela
COBRA PzF Coronary Stent System in Native Coronary Arteries for Early Healing, Thrombus Inhibition, Endothelialization, and Avoiding Long-Term Dual Anti-Platelet Therapy – The PzF SHIELD Trial
Mar 22, 2013The main objective of this study is to evaluate the safety and effectiveness of the COBRA PzF Coronary Stent System in the treatment of de novo lesions in native coronary arteries. The COBRA PzF Coronary Stent System is a balloon-expandable bare met...
Clinical Studies - Mar 22, 2013 - Mar 31, 2021
Completed
Project leader: Weilenmann Daniel
Members: Schneider Irene, Schefer Mirjam
CENTURY II
Jul 2, 2012Clinical Evaluation of new Terumo drug eluting coronary stent system in the treatment of patients with coronary artery disease.
Clinical Studies - Jul 2, 2012 - Jul 2, 2016
Completed
Project leader: Weilenmann Daniel
Members: Schneider Irene
ORSIRO
May 29, 2012Ein randomisierter Vergleich zwischen einem Sirolimus-freisetzenden Koronarstent mit bioderadierbarem Polymer und einem Everolimusbeschichteten Koronarstent mit einem nicht bioresorbierbaren Polymer bei Patienten mit einer koronaren Herzkrankheit, be...
Clinical Studies - May 29, 2012 - May 29, 2016
Completed
Project leader: Weilenmann Daniel
Members: Schefer Mirjam, Schneider Irene
STENTYS Sizing Registry
May 7, 2012The STENTYS Sizing Registry is a multinational post-marketing surveillance registry designed to evaluate large scale safety and reliability of the STENTYS Stents use in routine, worldwide daily practice. This internet-based registry will enroll 5000...
Clinical Studies - May 7, 2012 - Oct 31, 2019
Aborted
Project leader: Weilenmann Daniel
Members: Schneider Irene
OPEN II
Apr 24, 2012Assessment of Long-Term Safety and Efficacy of the STENTYS Paclitaxel-eluting self-expanding stent in coronary bifurcation lesions
Clinical Studies - Apr 24, 2012 - Dec 31, 2018
Completed
Project leader: Weilenmann Daniel
Members: Schefer Mirjam, Schneider Irene
Basket Small 2
Mar 21, 2012BASKET-SMALL 2 A prospective, randomized, controlled, open label, multicenter trial to test the non-inferiority of drug eluting balloon vs. drug eluting stent treatment in de novo stenoses of small native vessels regarding efficacy and safety
Clinical Studies - Mar 21, 2012 - Mar 21, 2016
Completed
Project leader: Weilenmann Daniel
Members: Rickli Hans, Gemperle Michaela, Schefer Mirjam
APPOSITION III
Feb 1, 2011A Post Market study to assess the STENTYS self-exPanding COronary Stent In AcuTe Myocardial InfarctiON in real life
Clinical Studies - Feb 1, 2011 - Jan 31, 2014
Completed
Project leader: Weilenmann Daniel
Members: Schefer Mirjam
DELUX Registry
Jul 14, 2010Evaluation of the safety profile of the Pantera Lux Paclitaxel releasing balloon for coronary arteries in daily clinical practice
Clinical Studies - Jul 14, 2010 - Jul 12, 2013
Completed
Project leader: Weilenmann Daniel
Members: Schefer Mirjam, Hottkowitz Chris
BASKET-PROVe II: Basel Stent Kosten Effektivitäts Trial-Prospektive Validation Examination, Teil II
Jun 1, 2010Das Ziel dieser Studie ist der Vergleich der Sicherheit 24 Monate nach Implantation eines neuartigen Baremetal-Stents gegenüber zwei neuartigen Drugeluting-Stents durch 2:1 Randomisierung bei unselektionierten Patienten mit niedrigem Restenose-Risiko...
Clinical Studies - Jun 1, 2010 - Jun 1, 2013
Completed
Project leader: Weilenmann Daniel
Members: Gemperle Michaela, Schefer Mirjam
INPUTon PE: Multizentrische, observationelle Überwachungsstudie zur Erkennung von chronisch thrombo-embolischem Lungenhochdruck nach einer Lungenembolie (PE)
Mar 1, 2010Evaluation der Inzidenz der symptomatischen CTEPH (chronische thrombo-embolische pulmonale Hypertonie) nach einer Lungenembolie. Identifizierung und Evaluation von potentiellen Risikofaktoren eine CTEPH nach einer Lungenembolie zu entwickeln. Brauchb...
Clinical Studies - Mar 1, 2010 - Mar 3, 2015
Completed
Project leader: Weilenmann Daniel
Members: Gemperle Michaela
SeQuent Please Registry
Jan 5, 2010The SeQuent Please Registry is an international, multi-center "all comer"/"real world" registry. The aim of the registry is to assess the safety and efficacy of the paclitaxel-eluting SeQuent Please drugeluting balloon and the optional combination to...
Clinical Studies - Jan 5, 2010 - May 1, 2012
Completed
Project leader: Weilenmann Daniel